*Terms and Conditions apply
1Godfrey, AR. Single dose crossover comparative bioavailability study of bupropion hydrochloride 450 mg extended release tablets and Wellbutrin XL® 150 mg extended release tablets in healthy male volunteers under fasting and fed conditions [clinical study report]. Laval, QC: Algorithme Pharma Inc; 2011.
FORFIVO XL® is a registered trademark of IntelGenx Corp. Wellbutrin XL is a registered
trademark of GlaxoSmithKline.